Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0006836,
umls-concept:C0006849,
umls-concept:C0016277,
umls-concept:C0018270,
umls-concept:C0019682,
umls-concept:C0019699,
umls-concept:C0030705,
umls-concept:C0086045,
umls-concept:C0205171,
umls-concept:C0205210,
umls-concept:C0205345,
umls-concept:C0242485,
umls-concept:C0681842,
umls-concept:C0871261,
umls-concept:C1704632,
umls-concept:C1705920,
umls-concept:C1706817,
umls-concept:C2911692
|
pubmed:issue |
2
|
pubmed:dateCreated |
1996-9-6
|
pubmed:abstractText |
The growth of 113 Candida spp. isolated prospectively from 104 HIV-positive patients treated for thrush was determined using a single concentration of 3 mg/L (10(-5) M) fluconazole relative to growth in drug free medium. Using a receiver operator characteristic curve, a relative growth in fluconazole of > or = 88% best discriminated between isolates from 56 patients who responded to treatment with fluconazole and 48 who failed to respond to 7 days, treatment with at least 100 mg/d drug with a sensitivity of 98% and a specificity of 96%. When the isolates from the eight patients with mixed infections due to both resistant and susceptible yeasts were excluded, the sensitivity and specificity both reached 100%. Relative growth of Candida spp. in a single concentration of fluconazole can therefore be used to accurately predict the clinical response to standard fluconazole treatment of thrush in patients infected with HIV.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0305-7453
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
37
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
275-83
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8707737-AIDS-Related Opportunistic Infections,
pubmed-meshheading:8707737-Antifungal Agents,
pubmed-meshheading:8707737-Candida,
pubmed-meshheading:8707737-Candidiasis, Oral,
pubmed-meshheading:8707737-Drug Resistance, Microbial,
pubmed-meshheading:8707737-Esophageal Diseases,
pubmed-meshheading:8707737-Evaluation Studies as Topic,
pubmed-meshheading:8707737-Fluconazole,
pubmed-meshheading:8707737-HIV Seropositivity,
pubmed-meshheading:8707737-Humans,
pubmed-meshheading:8707737-Microbial Sensitivity Tests,
pubmed-meshheading:8707737-Prospective Studies,
pubmed-meshheading:8707737-ROC Curve,
pubmed-meshheading:8707737-Reproducibility of Results
|
pubmed:year |
1996
|
pubmed:articleTitle |
Relative growth measurement of Candida species in a single concentration of fluconazole predicts the clinical response to fluconazole in HIV infected patients with oral candidosis.
|
pubmed:affiliation |
Department of HIV/Genito-urinary Medicine, Chelsea & Westminster Health Care Trust, London, UK.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|